Small Molecule Cancer Drug Market Report

Japan Small Molecule Cancer Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Dec 26, 2019
  • PAGES：204
  • REPORT CODE：GMM412674
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Small Molecule Cancer Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Small Molecule Cancer Drug market. Detailed analysis of key players, along with key growth strategies adopted by Small Molecule Cancer Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Astrazeneca

    • Boehringer

    • Johnson & Johnson

    • Roche

    • Novartis

    • Bayer

    • Cadila Pharmaceutical

    • Eli Lily

    • Merck

    By Type:

    • Cytokine

    • Humanized Monoclonal Antiboby

    • Others

    By End-User:

    • Lymphoma

    • Myeloma

    • Prostate Cancer

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Small Molecule Cancer Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Cytokine from 2014 to 2026

      • 1.3.2 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Humanized Monoclonal Antiboby from 2014 to 2026

      • 1.3.3 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Lymphoma from 2014 to 2026

      • 1.4.2 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Myeloma from 2014 to 2026

      • 1.4.3 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

      • 1.4.4 Japan Small Molecule Cancer Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Small Molecule Cancer Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Small Molecule Cancer Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Cytokine

      • 3.4.2 Market Size and Growth Rate of Humanized Monoclonal Antiboby

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Small Molecule Cancer Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Small Molecule Cancer Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Small Molecule Cancer Drug in Lymphoma

      • 4.4.2 Market Size and Growth Rate of Small Molecule Cancer Drug in Myeloma

      • 4.4.3 Market Size and Growth Rate of Small Molecule Cancer Drug in Prostate Cancer

      • 4.4.4 Market Size and Growth Rate of Small Molecule Cancer Drug in Others

    5 Market Analysis by Regions

    • 5.1 Japan Small Molecule Cancer Drug Production Analysis by Regions

    • 5.2 Japan Small Molecule Cancer Drug Consumption Analysis by Regions

    6 Hokkaido Small Molecule Cancer Drug Landscape Analysis

    • 6.1 Hokkaido Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    7 Tohoku Small Molecule Cancer Drug Landscape Analysis

    • 7.1 Tohoku Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    8 Kanto Small Molecule Cancer Drug Landscape Analysis

    • 8.1 Kanto Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 8.2 Kanto Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    9 Chubu Small Molecule Cancer Drug Landscape Analysis

    • 9.1 Chubu Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 9.2 Chubu Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    10 Kinki Small Molecule Cancer Drug Landscape Analysis

    • 10.1 Kinki Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 10.2 Kinki Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    11 Chugoku Small Molecule Cancer Drug Landscape Analysis

    • 11.1 Chugoku Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    12 Shikoku Small Molecule Cancer Drug Landscape Analysis

    • 12.1 Shikoku Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    13 Kyushu Small Molecule Cancer Drug Landscape Analysis

    • 13.1 Kyushu Small Molecule Cancer Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Small Molecule Cancer Drug Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Astrazeneca

      • 14.1.1 Astrazeneca Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Boehringer

      • 14.2.1 Boehringer Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Roche

      • 14.4.1 Roche Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Novartis

      • 14.5.1 Novartis Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Bayer

      • 14.6.1 Bayer Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Cadila Pharmaceutical

      • 14.7.1 Cadila Pharmaceutical Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Eli Lily

      • 14.8.1 Eli Lily Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Merck

      • 14.9.1 Merck Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 84 Figures and 132 Tables)

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Cytokine from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Humanized Monoclonal Antiboby from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Myeloma from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Small Molecule Cancer Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Small Molecule Cancer Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Small Molecule Cancer Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Small Molecule Cancer Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Small Molecule Cancer Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Cytokine

    • Figure Market Size and Growth Rate of Humanized Monoclonal Antiboby

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Small Molecule Cancer Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Small Molecule Cancer Drug by Different End-Users from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Lymphoma from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Myeloma from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

    • Figure Japan Small Molecule Cancer Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Small Molecule Cancer Drug Production by Regions

    • Table Japan Small Molecule Cancer Drug Production Share by Regions

    • Figure Japan Small Molecule Cancer Drug Production Share by Regions in 2014

    • Figure Japan Small Molecule Cancer Drug Production Share by Regions in 2018

    • Figure Japan Small Molecule Cancer Drug Production Share by Regions in 2026

    • Table Japan Small Molecule Cancer Drug Consumption by Regions

    • Table Japan Small Molecule Cancer Drug Consumption Share by Regions

    • Figure Japan Small Molecule Cancer Drug Consumption Share by Regions in 2014

    • Figure Japan Small Molecule Cancer Drug Consumption Share by Regions in 2018

    • Figure Japan Small Molecule Cancer Drug Consumption Share by Regions in 2026

    • Table Hokkaido Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Hokkaido Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Tohoku Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Tohoku Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Kanto Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Kanto Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Kanto Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Kanto Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Chubu Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Chubu Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Chubu Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Chubu Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Kinki Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Kinki Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Kinki Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Kinki Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Chugoku Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Chugoku Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Shikoku Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Shikoku Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Kyushu Small Molecule Cancer Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Small Molecule Cancer Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by Types in 2014

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by Types in 2018

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by Types in 2026

    • Table Kyushu Small Molecule Cancer Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Small Molecule Cancer Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Small Molecule Cancer Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Astrazeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astrazeneca

    • Figure Sales and Growth Rate Analysis of Astrazeneca

    • Figure Revenue and Market Share Analysis of Astrazeneca

    • Table Product and Service Introduction of Astrazeneca

    • Table Company Profile and Development Status of Boehringer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer

    • Figure Sales and Growth Rate Analysis of Boehringer

    • Figure Revenue and Market Share Analysis of Boehringer

    • Table Product and Service Introduction of Boehringer

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Cadila Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cadila Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Cadila Pharmaceutical

    • Figure Revenue and Market Share Analysis of Cadila Pharmaceutical

    • Table Product and Service Introduction of Cadila Pharmaceutical

    • Table Company Profile and Development Status of Eli Lily

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lily

    • Figure Sales and Growth Rate Analysis of Eli Lily

    • Figure Revenue and Market Share Analysis of Eli Lily

    • Table Product and Service Introduction of Eli Lily

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US